Breaking News: Embargoed Feed - hidden

Filters close
Newswise: 2024 Surinderjit Singh Young Lectureship Award Winner
10-May-2024 10:05 AM EDT
2024 Surinderjit Singh Young Lectureship Award Winner
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) is excited to announce Marcos V. Oliveira Marques, MD, as the 2024 Surinderjit Singh Young Lectureship Award recipient.

   
Query Closed
Reporter's Deadline Passed
9-May-2024 10:17 AM EDT
I'm doing a feature - Dinsa Sachan, Chemistry World
Newswise Expert Queries

I'm doing a feature piece on science communication officers that looks at their role

access_time Embargo lifts in 2 days
This news release is embargoed until 13-May-2024 5:00 AM EDT Released to reporters: 10-May-2024 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Left Before Reporter's Deadline
Reporter's Deadline: 13-May-2024 5:00 PM EDT
10-May-2024 9:15 AM EDT
How often do bed pillows - Amelia Jerden, The Strategist / New York Magazine

How often do bed pillows need to be replaced? The common rule of thumb appears

   
Newswise: Worker rights are one of the least protected human rights, new research reveals
1-May-2024 9:10 AM EDT
Worker rights are one of the least protected human rights, new research reveals
Binghamton University, State University of New York

Worker rights are among the least protected human rights in the world, according to new research from faculty at Binghamton University, State University of New York.

access_time Left Before Reporter's Deadline
Reporter's Deadline: 14-May-2024 7:00 PM EDT
10-May-2024 7:53 AM EDT
I run a quarterly digital - Madeleine Hall,

I run a quarterly digital publication on all things innovation. In our upcoming edition, due

Newswise: Metabolism of Autism Reveals Developmental Origins
8-May-2024 5:05 PM EDT
Metabolism of Autism Reveals Developmental Origins
University of California San Diego

New insights into the metabolism of autism from researchers at UC San Diego could help inform early detection and prevention strategies for the disorder.

Not for public release

This news release is embargoed until 13-May-2024 5:00 AM EDT Released to reporters: 10-May-2024 1:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Query Closed
Reporter's Deadline Passed
6-May-2024 5:03 AM EDT
I will like to have - Kehinde Akinseinde-Jayeoba, African Newspaper of Nigeria Plc
Newswise Expert Queries

I will like to have an in-depth expert analysis on the recapitalisation drive of

Query Closed
Reporter's Deadline Passed
3-May-2024 10:45 AM EDT
- Neil A Osterweil, MDedge/Medscape
Newswise Expert Queries

I'm writing a piece for MDedge Oncology

access_time Embargo lifts in 2 days
This news release is embargoed until 17-May-2024 8:35 AM EDT Released to reporters: 9-May-2024 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-May-2024 8:35 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 13-May-2024 9:00 AM EDT Released to reporters: 9-May-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2024 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 16-May-2024 8:25 AM EDT Released to reporters: 9-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2024 8:25 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

8-May-2024 5:05 PM EDT
Study Shows Ineffectiveness of Targeted Credit Rationing in Banking
University of Maryland, Robert H. Smith School of Business

With the recent ESG-inspired shift towards and away from the rationing of capital to specific firms that arguably generate negative externalities, a new study shows targeted credit rationing in recent history has been widely ineffective in promoting change.

access_time Embargo lifts in 2 days
This news release is embargoed until 16-May-2024 1:20 PM EDT Released to reporters: 9-May-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2024 1:20 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Query Closed
Reporter's Deadline Passed
7-May-2024 12:00 PM EDT
Right now, I’m researching - Dinsa Sachan, Chemistry World
Newswise Expert Queries

Right now, I’m researching a story on science communications officers for Chemistry World. The

3-May-2024 3:05 PM EDT
Study: Neuropathy Very Common, Underdiagnosed
American Academy of Neurology (AAN)

Neuropathy, the nerve damage that causes pain and numbness in the feet and hands and can eventually lead to falls, infection and even amputation, is very common and underdiagnosed, according to a study published in the May 8, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: Strengthening CAR-T Therapy to Work Against Solid Tumors
7-May-2024 10:00 AM EDT
Strengthening CAR-T Therapy to Work Against Solid Tumors
Montefiore Einstein Cancer Center

Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors—an advance that could transform cancer treatment. The promising findings, reported today in Science Advances, involve CAR-T cell therapy, which supercharges the immune system to identify and attack cancer cells.

access_time Embargo lifts in 2 days
This news release is embargoed until 16-May-2024 10:35 AM EDT Released to reporters: 8-May-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2024 10:35 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Mount Sinai Scientists Unravel How Psychedelic Drugs Interact with Serotonin Receptors to Potentially Produce Therapeutic Benefits
7-May-2024 3:05 PM EDT
Mount Sinai Scientists Unravel How Psychedelic Drugs Interact with Serotonin Receptors to Potentially Produce Therapeutic Benefits
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatric disorders such as depression and anxiety.

Newswise: GUIDE team develops computational approach to redesign antibodies for broader effectiveness against viral pandemics
7-May-2024 6:05 PM EDT
GUIDE team develops computational approach to redesign antibodies for broader effectiveness against viral pandemics
Lawrence Livermore National Laboratory

In a groundbreaking development for addressing future viral pandemics, a multi-institutional team involving Lawrence Livermore National Laboratory researchers has successfully combined an artificial intelligence-backed platform with supercomputing to redesign and restore the effectiveness of antibodies whose ability to fight viruses has been compromised by viral evolution. The work was published in the journal Nature.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 15-May-2024 10:30 AM EDT Released to reporters: 8-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-May-2024 10:30 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Honoring Oncology Nurses at the State’s Only NCI-designated Comprehensive Cancer Center
7-May-2024 2:05 PM EDT
Honoring Oncology Nurses at the State’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Three nurses have been named recipients of Rutgers Cancer Institute’s ‘Oncology Nursing Excellence Awards’ during Nurses Week this year. This year’s award recipients were named during the annual Elizabeth Gibby Osborne Lecture.

Newswise:Video Embedded swarms-of-miniature-robots-clean-up-microplastics-and-microbes-simultaneously-video
VIDEO
3-May-2024 8:00 AM EDT
Swarms of miniature robots clean up microplastics and microbes, simultaneously (video)
American Chemical Society (ACS)

In a study in ACS Nano, researchers describe swarms of microscale robots (microrobots) that captured bits of plastic and bacteria from water. Afterward, the bots were decontaminated and reused.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 16-May-2024 11:10 AM EDT Released to reporters: 8-May-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2024 11:10 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-May-2024 8:00 PM EDT Released to reporters: 8-May-2024 6:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-May-2024 8:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: ‘Mathematical microscope’ reveals novel, energy-efficient mechanism of working memory that works even during sleep
6-May-2024 5:05 PM EDT
‘Mathematical microscope’ reveals novel, energy-efficient mechanism of working memory that works even during sleep
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health researchers have discovered a mechanism that creates memories while reducing metabolic cost, even during sleep. This efficient memory occurs in a part of the brain that is crucial for learning and memory, and where Alzheimer’s disease begins.

7-May-2024 5:05 AM EDT
Unlocking insights into insomnia
University of Bristol

GP data can provide unique insights into common health conditions, new research looking at insomnia symptom prevalence in England has shown. The University of Bristol-led study, published in BMJ Open today [8 May], also highlights the value of improving access to this data for future health research.

Query Closed
Reporter's Deadline Passed
2-May-2024 5:36 PM EDT
Sickle cell therapies, access, history — - Maryn McKenna, Scientific American
Newswise Expert Queries

Sickle cell therapies, access, history — For a piece pegged to the approval of gene therapies

   
access_time Embargo lifts in 2 days
This news release is embargoed until 14-May-2024 3:00 PM EDT Released to reporters: 7-May-2024 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-May-2024 3:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   

Not for public release

This news release is embargoed until 13-May-2024 4:00 PM EDT Released to reporters: 7-May-2024 1:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 16-May-2024 10:00 AM EDT Released to reporters: 7-May-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2024 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Seeking Medical Insights in the Physics of Mucus
2-May-2024 1:05 PM EDT
Seeking Medical Insights in the Physics of Mucus
American Institute of Physics (AIP)

Understanding how mucus changes, and what it changes in response to, can help diagnose illnesses and develop treatments. In APL Bioengineering, researchers develop a system to grow mucus-producing intestinal cells and study the characteristics of the mucus in different conditions.

   
Newswise: Study Sheds Light on Cancer Cell ‘Tug-of-War’
1-May-2024 3:05 PM EDT
Study Sheds Light on Cancer Cell ‘Tug-of-War’
American Institute of Physics (AIP)

In APL Bioengineering, researchers used a breast cancer cell line panel and primary tumor explants from breast and cervical cancer patients to examine two different cellular contractility modes: one that generates collective tissue surface tension that keeps cell clusters compact and another, more directional, contractility that enables cells to pull themselves into the extracellular matrix.

   
Newswise: BGSU to accept Herschend host tuition for Resort and Attraction Management program
7-May-2024 8:00 AM EDT
BGSU to accept Herschend host tuition for Resort and Attraction Management program
Bowling Green State University

Through BGSU Online, Herschend employees will be able to enroll in the one-of-a-kind Resort and Attraction Management program and can continue working while completing their degree

access_time Embargo lifts in 2 days
This news release is embargoed until 15-May-2024 10:15 AM EDT Released to reporters: 7-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-May-2024 10:15 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

4-May-2024 7:05 PM EDT
Globus Announces Multi-User Support for Globus Compute
Globus

Globus, the de facto standard platform for research IT, announced multi-user support for Globus Compute, a service that enables reliable, scalable, and high performance remote function execution, and delivers the same “fire-and-forget” capabilities for computation as the Globus core platform does for data management.

Not for public release

This news release is embargoed until 6-May-2024 5:00 PM EDT Released to reporters: 30-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 6-May-2024 5:00 PM EDT Released to reporters: 30-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 6-May-2024 5:00 PM EDT Released to reporters: 30-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Sylvester Researchers Develop a Nanoparticle That Can Penetrate the Blood-Brain Barrier
2-May-2024 8:05 PM EDT
Sylvester Researchers Develop a Nanoparticle That Can Penetrate the Blood-Brain Barrier
Sylvester Comprehensive Cancer Center

Researchers at Sylvester Comprehensive Cancer Center have developed a nanoparticle that can penetrate the blood-brain barrier. Their goal is to kill primary breast cancer tumors and brain metastases in one treatment.

access_time Embargo lifts in 2 days
This news release is embargoed until 13-May-2024 4:00 PM EDT Released to reporters: 6-May-2024 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 13-May-2024 8:30 AM EDT Released to reporters: 6-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2024 8:30 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   

Not for public release

This news release is embargoed until 6-May-2024 8:00 AM EDT Released to reporters: 2-May-2024 8:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-May-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 14-May-2024 9:45 AM EDT Released to reporters: 6-May-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-May-2024 9:45 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

5-May-2024 7:05 PM EDT
Research to Prevent Blindness Opens Applications for Vision Research Grants
Research to Prevent Blindness

Research to Prevent Blindness is pleased to announce that it has opened a new round of grant funding for high-impact vision research, including research related to glaucoma, age-related macular degeneration, inherited retinal diseases, myopia, amblyopia, low vision and many more.

30-Apr-2024 10:05 AM EDT
Survey of U.S. Parents Highlights Need for More Awareness About Newborn Screening, Cystic Fibrosis and What to Do if Results are Abnormal
Ann and Robert H. Lurie Children's Hospital of Chicago

A national survey led by Ann & Robert H. Lurie Children’s Hospital of Chicago found that parents have insufficient knowledge of newborn screening in general and of cystic fibrosis (CF) in particular.

5-May-2024 9:00 AM EDT
The American Association of Immunologists Partners with Oxford University Press to Publish Preeminent Immunology Journals  
American Association of Immunologists (AAI)

The American Association of Immunologists (AAI) today announced its publishing partnership with Oxford University Press (OUP). OUP will publish the AAI journals, The Journal of Immunology (The JI) and ImmunoHorizons (IH), beginning in 2025. 

   
Query Closed
Reporter's Deadline Passed
1-May-2024 9:23 AM EDT
Right now, I’m researching - Dinsa Sachan,
Newswise Expert Queries

Right now, I’m researching a story on science communications officers for Chemistry World . The

3-May-2024 7:00 PM EDT
American Association of Immunologists (AAI) Introduces New Brand Identity
American Association of Immunologists (AAI)

Today the American Association of Immunologists (AAI), one of the world’s largest organizations of immunologists and scientists in related disciplines, is proud to announce the launch of its new brand identity.

   


close
7.492